Rezultati - Lassen, U

Direct measurements of membrane potential and membrane resistance of human red cells od Lassen, U. V., Sten-Knudsen, O.

Polni tekst Polni tekst

P16.23 A COMPARISON OF 18F-FET AND 18F-FLT MICROPET FOR THE ASSESSMENT OF ANTI-VEGF EFFICACY IN AN ORTHOTOPIC MURINE MODEL OF GLIOBLASTOMA od Nedergaard, M.K., Michaelsen, S.R., Poulsen, H.S., Lassen, U., Stockhausen, M., Kjær, A.

Polni tekst Polni tekst

Early death during chemotherapy in patients with small-cell lung cancer: derivation of a prognostic index for toxic death and progression od Lassen, U N, Østerlind, K, Hirsch, F R, Bergman, B, Dombernowsky, P, Hansen, H H

Polni tekst Polni tekst Polni tekst

A phase I, dose-escalation study of TB-403, a monoclonal antibody directed against PlGF, in patients with advanced solid tumours od Lassen, U, Nielsen, D L, Sørensen, M, Winstedt, L, Niskanen, T, Stenberg, Y, Pakola, S, Stassen, J-M, Glazer, S

Polni tekst Polni tekst Polni tekst

P17.91 CLINICAL VARIABLES SERVE AS PREDICTIVE FACTORS IN A MODEL FOR CLINICAL RESPONSE TO BEVACIZUMAB IN RECURRENT GLIOBLASTOMA MULTIFORME: AN OBSERVATIONAL STUDY OF A COHORT OF CO... od Urup, T., Grunnet, K., Christensen, I.J., Michaelsen, S.R., Broholm, H., Stockhausen, M.T., Lassen, U., Poulsen, H.S.

Polni tekst Polni tekst

P08.06 Transcriptional changes induced by bevacizumab combination therapy in responding and non-responding recurrent glioblastoma patients od Urup, T., Staunstrup, L., Michaelsen, S., Vitting-Seerup, K., Bennedbæk, M., Toft, A., Broholm, H., Hamerlik, P., Poulsen, H., Lassen, U.

Polni tekst Polni tekst

A phase I study of the safety and pharmacokinetics of the histone deacetylase inhibitor belinostat administered in combination with carboplatin and/or paclitaxel in patients with s... od Lassen, U, Molife, L R, Sorensen, M, Engelholm, S-A, Vidal, L, Sinha, R, Penson, R T, Buhl-Jensen, P, Crowley, E, Tjornelund, J, Knoblauch, P, de Bono, J S

Polni tekst Polni tekst Polni tekst

A Comparison of Endoscopic Ultrasound Guided Biopsy and Positron Emission Tomography with Integrated Computed Tomography in Lung Cancer Staging od Larsen, S.S., Vilmann, P., Krasnik, K., Dirksen, Asger, Clementsen, P., Skov, Birgit G., Jacobsen, Grete Krag, Lassen, U., Eigtved, Annika, Berthelsen, Anne Kiil, Mortensen, J., Hoejgaard, Liselotte

Polni tekst Polni tekst

Safety and clinical activity of the Notch inhibitor, crenigacestat (LY3039478), in an open-label phase I trial expansion cohort of advanced or metastatic adenoid cystic carcinoma od Even, C., Lassen, U., Merchan, J., Le Tourneau, C., Soria, J-C, Ferte, C., Ricci, F., Diener, J. T., Yuen, E., Smith, C., Oakley, G. J., Benhadji, K. A., Massard, Christophe

Polni tekst Polni tekst Polni tekst

OS2.2 Highly personalized peptide vaccination for patients with newly diagnosed glioblastoma: the GAPVAC trial od Dietrich, P, Wick, W, Hilf, N, Frenzel, K, Gouttefangeas, C, Platten, M, thor Straten, P, Lassen, U, Rodon, J, Bukur, V, Admon, A, van der Burg, S H, von Deimling, A, Kroep, J R, Martinez-Ricarte, F, Okada, H, Ottensmeier, C H, Ponsati, B, Poulsen, H S, Stevanovic, S, Tabatabai, G, Rammensee, H, Sahin, U, Singh-Jasuja, H

Polni tekst Polni tekst

Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children od Drilon, A., Laetsch, T.W., Kummar, S., DuBois, S.G., Lassen, U.N., Demetri, G.D., Nathenson, M., Doebele, R.C., Farago, A.F., Pappo, A.S., Turpin, B., Dowlati, A., Brose, M.S., Mascarenhas, L., Federman, N., Berlin, J., El-Deiry, W.S., Baik, C., Deeken, J., Boni, V., Nagasubramanian, R., Taylor, M., Rudzinski, E.R., Meric-Bernstam, F., Sohal, D.P.S., Ma, P.C., Raez, L.E., Hechtman, J.F., Benayed, R., Ladanyi, M., Tuch, B.B., Ebata, K., Cruickshank, S., Ku, N.C., Cox, M.C., Hawkins, D.S., Hong, D.S., Hyman, D.M.

Polni tekst Polni tekst Polni tekst